BELRAPZO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Feb 2025)
What this means for you
Registered since 24 Sept 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87866979
- Registration number
- 5869212
- Mark type
- Stylized text
- Filed
- 06 Apr 2018
- Published for opposition
- 04 Sept 2018
- Registered
- 24 Sept 2019
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- Eagle Pharmaceuticals, Inc., Woodcliff Lake, NJ, US
- Eagle Pharmaceuticals, Inc., Woodcliff Lake, NJ, US
- Eagle Pharmaceuticals, Inc., Woodcliff Lake, NJ, US
Prosecution history
- 06 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 24 Sept 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Sept 2019 — REGISTERED-PRINCIPAL REGISTER
- 23 Aug 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Aug 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Aug 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Jul 2019 — USE AMENDMENT FILED
- 21 Aug 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jul 2019 — TEAS STATEMENT OF USE RECEIVED
- 06 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2019 — SOU EXTENSION 1 GRANTED
- 04 Mar 2019 — SOU EXTENSION 1 FILED